Related Experiment Video
Updated: Jul 17, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
[Artifitial increase of HIV-1 reverse transcriptase turnover through proteasome pathway]
Molekuliarnaia Biologiia
|January 11, 2007
Summary
To enhance DNA vaccine efficacy, researchers fused HIV-1 reverse transcriptase with ornithine decarboxylase. This fusion significantly increased proteasome-mediated degradation of reverse transcriptase, improving its presentation.
Area of Science:
- Molecular Biology
- Immunology
- Virology
Background:
- The proteasome is crucial for antigen presentation via the MHC class I pathway.
- Enhancing proteasome targeting of DNA vaccine-encoded proteins is an active area of research.
- HIV-1 reverse transcriptase, used in DNA vaccines, exhibits slow cellular degradation (18-20h half-life).
Purpose of the Study:
- To increase the proteasome-mediated degradation rate and affinity of HIV-1 reverse transcriptase.
- To improve the presentation of reverse transcriptase in DNA vaccines.
Main Methods:
- Investigated HIV-1 reverse transcriptase degradation using proteasome inhibitors (MG132, epoxomicin).
- Created a fusion protein of reverse transcriptase and ornithine decarboxylase, known for rapid, ubiquitin-independent proteasomal degradation.
- Assessed the half-life and proteasome inhibitor sensitivity of the fusion protein compared to native reverse transcriptase.
Main Results:
- Reverse transcriptase degradation was confirmed to be proteasome-dependent, with MG132 showing a stronger effect than epoxomicin, suggesting involvement of other proteases.
- The fusion protein exhibited a significantly reduced half-life (3 hours, 6-fold decrease) compared to native reverse transcriptase.
- Degradation of the fusion protein was inhibited 10 times more effectively by proteasome inhibitors, indicating enhanced proteasomal targeting.
Conclusions:
- Fusion with ornithine decarboxylase effectively enhances the proteasome-mediated degradation of HIV-1 reverse transcriptase.
- This strategy holds promise for improving the immunogenicity and performance of DNA vaccines encoding reverse transcriptase.
More Related Videos
Related Concept Videos
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
00:36Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:26Size and Structure of Viral Genomes
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
01:29Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
01:13The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...